Skip to main content
Advertisement
Advertisement

FRNM

FRNM logo

Freenome, Inc. Common stock

14.37
USD
Sponsored
-0.42
-2.84%
Sep 11, 15:59 UTC -4
Closed
exchange

After-Market

14.68

+0.31
+2.19%

Freenome, Inc. Common stock Profile

About

Freenome is an early cancer detection company developing blood-based screening tests to detect cancer when it is most treatable. The company's Personalized Cancer Detection approach combines multiomics, artificial intelligence and machine learning to develop screening tests tailored to the biology of individual cancers and the needs of specific patient populations. Freenome's first commercial-stage test, SimpleScreen(TM) CRC, is an FDA-approved blood-based screening test for colorectal cancer in adults 45 and older who are at average risk for the disease. Beyond colorectal cancer, Freenome continues to advance a pipeline of non-invasive single- and multi-cancer screening tests across additional cancer indications, in pursuit of its mission to make cancer screening more accessible and increase participation.

Info & Links

CEO

Adam Stone

Headquarters

51 ASTOR PLACE, 10TH FLOOR
NEW YORK, NY 10003, UNITED STATES

Industry

Medical Services

Sector

Medical

Website

https://www.perceptivelife.com/pcsc

Auditor

WithumSmith+Brown, PC

Share holders

39

Employees

--

Freenome, Inc. Common stock Statistics

Valuation Measures

Market Capitalization2

1.58B

Enterprise Value

1.58B

Enterprise Value/EBITDA(ttm)

-364.15

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

152.99

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-2.70%

Return on Invested Capital(ttm)

13.55%

Return on Assets(ttm)

-0.84%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-4.33M

Net Income Available to Common(ttm)

-762.60K

Diluted EPS(ttm)

-0.06

Share Statistics

Beta (5Y Monthly)

0.48

52-Week Change

--

S&P 500 52-Week Change

18.73%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

10.31M

Dividend Yield

0.00%

Float4

83.74M

% Held by Insiders

22.06%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

437.40K

Total Cash Per Share(mrq)

0.04

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.20%

Quick Ratio(mrq)

0.20%

Book Value Per Share(mrq)

-2.58

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.18

Free Cash Flow(ytd)

-427.70K

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement